Acetylcysteine Treatment of Acetaminophen Overdose: Foundational and Clinical Development
N-acetyl para-aminophenol was suggested as a safer alternative to other drugs on the market for pain and fever in 1948. It was given the generic name “acetaminophen” in 1951 and the trade name “Tylenol” when it was put on the market in the USA in 1955 as a prescription drug to treat pediatric fever....
Saved in:
Main Author: | Barry H. Rumack |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-04-01
|
Series: | Livers |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-4389/5/2/20 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The clinical value of screening for acetaminophen in all patients with intentional overdose or altered mental status suspected to be secondary to overdose
by: Bader Alyahya, et al.
Published: (2025-07-01) -
Expanding Horizons – A Broad-Spectrum Review of Emerging Medical Applications of N-Acetylcysteine
by: Oskar Mikołajczyk, et al.
Published: (2025-07-01) -
Application of N-Acetyl-Glucosaminil-N-Acetyl-Muramyl Dipeptide during Triple Component Anti-Helicobacter Pylori Therapy in the Period of Coronavirus Infection COVID-19
by: M. R. Konorev, et al.
Published: (2023-08-01) -
Influence of the Acetylation Type on the Incidence of Isoniazid-Induced Hepatotoxicity in Patients with Newly Diagnosed Pulmonary Tuberculosis
by: N. M. Krasnova, et al.
Published: (2020-11-01) -
The role of NMDAR antibody in the etiopathogenesis of schizophrenia
by: Timucin D, et al.
Published: (2016-09-01)